Review
Accepted on 03 Apr 2025
A potential prognostic marker for hematologic neoplasms: CD58
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1586842
Type at least 3 characters
1,815 articles
Case Report
Accepted on 03 Apr 2025
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e13a3 fusion transcripts in a Patient with Pre-existing Essential Thrombocythemia: A Case Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1573893
Perspective
Published on 01 Apr 2025
Total skin electron beam therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1498855
- 148 views
Case Report
Published on 01 Apr 2025
18F-FDG PET/CT in the diagnosis and treatment of atypical extensive skin lesions in extranodal natural killer/T-cell lymphoma, nasal type: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1480661
- 138 views
Review
Accepted on 31 Mar 2025
Targeting BCL2 in Waldenström Macroglobulinemia: From biology to treatment management
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1564869
Original Research
Published on 31 Mar 2025
Increased TIGIT expression correlates with impaired NK cell function in diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1551061
- 263 views
Original Research
Published on 31 Mar 2025
The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1456832
- 188 views
Editorial
Published on 27 Mar 2025
Editorial: Elderly patients and lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1568846
- 202 views
Case Report
Published on 27 Mar 2025
Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/MECOM rearrangement
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1530852
- 390 views
Original Research
Accepted on 26 Mar 2025
TP53 mutation and immunohistochemical p53 expression characteristics in diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1550207
Case Report
Published on 25 Mar 2025
Endoscopic ultrasound-guided fine-needle aspiration in diagnosing primary medistinal large B-cell lymphoma: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1404211
- 202 views
Brief Research Report
Published on 25 Mar 2025
Identification of a novel NRF1::PDGFRA fusion in myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1552928
- 220 views
Original Research
Accepted on 24 Mar 2025
IMPACT OF PRIMARY CANCER HISTORY AND MOLECULAR LANDSCAPE IN THERAPY-RELATED MYELOID NEOPLASMS
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1563990
Systematic Review
Accepted on 21 Mar 2025
Atopic dermatitis and lymphoma risk: a systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1580550
- 178 views
Mini Review
Published on 21 Mar 2025
The potential role of BCL-2 inhibition in amyloidosis and plasma cell leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1549891
- 679 views
Original Research
Published on 21 Mar 2025
A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1549809
- 197 views